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Abstract. In cultured chicken myotubes, calcitonin 
gene-related peptide (CGRP), a peptide present in spi- 
nal cord motoneurons,  increased by 1.5-fold  the num- 
ber of surface acetylcholine receptors (AChRs) and by 
threefold AChR ~t-subunit  mRNA level without affect- 
ing the level of muscular t~-actin mRNA.  Cholera 
toxin (CT), an activator of adenylate cyclase, produced 
a  similar effect, which did not add up with that of 
CGRP. In contrast,  tetrodotoxin,  a blocker of voltage- 
sensitive Na  § channels,  elevated the level of AChR 
a-subunit mRNA on top of the increase caused by ei- 
ther CGRP or CT. 
L2-O-Tetradecanoyl phorbol-B-acetate (TPA), an acti- 
vator of protein kinase C, markedly decreased the cell 
surface and total content of [L25I]ctBGT-binding sites 
and reduced the rate of appearance of AChR at the 
surface of the myotubes without reducing the level of 
AChR ~t-subunit  mRNA.  Moreover, TPA inhibited the 
increase of AChR ~t-subunit  mRNA caused by tetro- 
dotoxin without affecting that produced by CGRP or 
CT.  Under the same conditions, TPA decreased the 
level of muscular ~t-actin mRNA and increased that of 
nonmuscular 13- and "/-actins  mRNA. 
These data suggest that distinct second messengers 
are involved in the regulation of AChR biosynthesis by 
CGRP and muscle activity and that these two path- 
ways may contribute to the development of different 
patterns of AChR gene expression in junctional and 
extrajunctional  areas of the muscle fiber. 
T 
He. nicotinic  acetylcholine receptor (AChR) ~  is an in- 
tegral membrane protein, composed of five transmem- 
brane subunits (~t213)'8) (8). Under the nerve endings, 
the number of receptor molecules steadily increases during 
the maturation  of the neuromuscular junction, and then re- 
mains very high  in  the adult junction;  in contrast,  extra- 
synaptic receptor density falls to negligible values (9, 15, 29). 
The decline of extrajunctional  AChR has been related to the 
repression of AChR biosynthesis by the neurally evoked elec- 
trical  activity of the developing  muscle fiber (9,  15,  29). 
What then are the mechanisms  that would account for the 
persistence of AChR incorporationat the level of the growing 
subneural domain? Several attempts have been made to iden- 
tify neural  factors  that might plausibly be involved in this 
process, by following the increase of AChR levels in cultured 
muscle cells caused by extracts  of neural tissues and/or by 
a variety of  pharmacological agents (reviewed in 29), includ- 
ing, most recently, the neuropeptide calcitonin gene-related 
peptide (CGRP) (14, 25). 
CGRP  is  a  widely  distributed  peptide  generated  by 
differential  RNA processing from a  single genomic locus 
1.  Abbreviations  used  in  this  paper:  AChR,  acetylcholine  receptors; 
[125I]tt-BGT, 125I-labeled a-bungarotoxin;  CGRP, calcitonin  gene-related 
peptide; CT, cholera toxin; TTX, tetrodotoxin. 
which also codes for calcitonin  (28).  CGRP exerts  several 
biological actions such as cardiovascular  effects, inhibition 
of gastric secretion, and ingestive behavior (13) and has been 
proposed to act as a neurotransmitter  in the sensory tract 
(33).  Interestingly,  CGRP has been localized  by immuno- 
histochemistry  in  chicken  motoneurons  (14, 25)  and  in 
mouse (32) or rat tongue (31) motor end-plates.  Moreover, 
the peptide was found to be colocalized with acetylcholine 
in rat neurons of several motor systems (31). CGRP may thus 
serve as a coexisting neuronal messenger (7, 16). Consistent 
with  such  a  role,  CGRP is released from cultures  of rat 
trigeminal  cells (21) and enhances skeletal muscle contrac- 
tion (32).  Furthermore, it was recently shown that addition 
of CGRP to chick muscle cells in primary cultures  signifi- 
cantly increases  the level of surface AChR (14, 25). 
In this paper, we demonstrate that CGRP significantly ele- 
vates AChR ~t-subunit mRNA levels in primary chick myo- 
tubes in culture.  To further identify the intracellular  path- 
ways involved in this  effect,  a  variety  of pharmacological 
agents were tested. We report that cholera toxin (CT), an ac- 
tivator ofadenylate cyclase, and 12-O-tetradecanoyl phorbol- 
B-acetate (TPA), an activator  of protein kinase C (6, 27), 
exert different effects on the levels of AChR and AChR a-sub- 
unit mRNA. Similar experiments  with CT or TPA were also 
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a Mocker of muscle electrical activity. The data are inter- 
preted in terms of a model of AChR genes regulation during 
the development of the neuromuscular  junction according to 
which CGRP and muscle electrical activity might respec- 
tively contribute to the maintenance of AChR gene expres- 
sion in junctional areas and to the disappearance of AChR 
in extrajunctional areas via distinct intracellular pathways. 
Materials and Methods 
Myotube Culture 
Myoblasts were obtained from the hind limbs of H-d-old chick embryos 
(Centre Avicole  de rile de France, Arpajon) by mechanical dissociation and 
cultured as described (2). Briefly, the cells were seeded in gelatine-coated 
plastic dishes at a density of 104 cells/ram  2 and cultivated in a 3:1 mixture 
of MEM (Gibco, Grand Island, NY) and medium 199 (Gibco), containing 
10% horse serum (Gibco) and 1% chick embryo extract. From 48 to 96 h 
of culture, the cells were treated with 10  -5 M cytosine arabinnside (Sigma 
Chemical Co., St. Louis, MO) to minimize fibroblast proliferation. Media 
were then reneged every 2 or 3 d. 
Treatments with Pharmacological Agents 
The agents were added after 6 d of culture directly into the medium. Syn- 
thetic rat CGRP (10  -7 M final concentration) was purchased from Bachem 
Feinchemikalien (Bubendorf, Switzerland), CT (25 ng/ml final concentra- 
tion), a gift of Dr. A. Monneron, was from Makor Chemicals (Jerusalem, 
Israel) and TTX (0.1 IJg/ml final concentration) was from Sigma Chemical 
Co. After 24-40 h of incubation with cultured myotubes, CGRP-supple- 
mented media were still able to increase the level of  AChR when transferred 
to a nontreated culture dish (data not shown). Moreover, AChR levels did 
not further increase upon adding a  fresh CGRP solution to the culture 
medium, indicating that CGRP was not or only slightly inactivated during 
the experiment. 
TPA (Sigma Chemical Co.) and 4-a-phorbol 12-13 didecanoate (gift of 
Dr. Castagna) were dissolved at 1 mg/rnl in 1% DMSO. 1,000-fold dilution 
of a 1% DMSO solution into the culture medium had no effect on myotubes 
as judged by phase-contrast microscopy and surface AChR number. 
Quantification of  AChR Levels with 
I  uJI]-a-Bungarotoxin 
Surface AChR levels (2) were measured by t2SI-labeled a-bungarotoxin 
([mI]aBGT; sp act =  200 Ci/mmol; Amersham Corp., Arlington Heights, 
IL) binding to duplicate 35-ram dishes. Non-specific binding was deter- 
mined after 30 rain of preincubation with, and in the subsequent presence 
of, 10  -5 M decamethonium, and was subtracted from all values (5-10% de- 
pending on the [ml]aBGT batches). 
The metabolic rate of degradation of surface AChR was estimated by fol- 
lowing the life-time of the AChR-aBGT complex. Cultures treated with 20 
ng/ml TPA for 24 h  and control cultures were labeled in parallel with 
[t~I]aBGT.  After 0.5 h  at 37~  the cells were washed free of unbound 
toxin and cultured in TPA-supplemented or control medium. At different 
time intervals, duplicate dishes were removed and the amount of  remaining 
bound radioactivity was determined. 
The rate of insertion of  AChR into the sarcolemmai membrane was deter- 
mined after 24 h of preineubation with TPA (20 ng/ml) or CGRP (10  -7 M). 
The cells were incubated with  10  -7 M  aBGr (Signm Chemical Co.) for 
0.5 h in MEM at 370C, washed four times with MEM, and incubated again 
in the medium that had been removed before incubation with aBGT (sup- 
plemented with CGRP or TPA where necessary). At different  time intervals, 
cells were incubated with 10 nM [ml]aBGT for 0.5 h. After four washes 
with PBS (pH 7), radioactivity of a  1% Triton X-100-1 M NaOH extract 
was determined in a gamma counter (LKB-WalIac,  Turku, Finland). 
Total receptor content was determined in 1% Triton X-100-10 mM NaCI- 
10 mM Tris-HC! (pH 7.4) extracts (12). After 5 rain of incubation in this 
solution, cells were homogenized with a glass-teflon homogenizer. Cen- 
trifugation at 7,000 g during 30 rain was performed to remove insoluble ma- 
terial. The supernatant was then incubated with 10 nM [mI]aBGr during 
1 h at 370C. Nonspecitic binding of aBGT was determined by the binding 
of [mI]aBGT after 1 h of preineubation in the presence of 10  -7 M aBGT. 
Each sample was then filtered through three stacked DES1 filters (Whatman 
Inc., Clifton, NJ), which were washed with 5-10 mt of  a solution containing 
1% Triton X-100, 10 mM NaCI,  10 mM Tris-HC1  (pH 7.4). 
Total Protein Content and Incorporation 
of pSS]Methionine 
Total protein content was measured in extracts by the Coomassie Blue tech- 
nique (Bio-Rad Laboratories, Richmond, CA). The rate of incorporation of 
[35Slmethionine  was determined in triplicate 20 ng/ml TPA-supplemented 
and control dishes. The medium was replaced by medium free of methio- 
nine, with TPA where necessary. [35S]melhionine (100 txCitml;  Amersham 
Corp.) was then added and incorporation was allowed to proceed for 2-4 
h.  The cells were washed twice with PBS (pH 7) and extracted in  t  M 
NaOH containing 5 mM L-methionine. The 10% TeA-insoluble radioactiv- 
ity was determined in aliquots by a glass fiber filter assay procedure and ex- 
pressed relative to the total radioactivity measured in the same extract. 
Results were corrected for the nonspecific binding of [35Slmethionine which 
was determined at time zero. 
Northern Blot  Analysis 
Total RNA was prepared from pools of four 100-mm culture dishes. After 
two washings with PBS (pH 7) and one with 0.25 M NaCI-10 mM Tris-HCl 
(pH 7.5)-10 mM MgCI2, the cells were scraped with a rubber policeman, 
and lysis was performed in 4 M urea-2 M LiCI by slowly pipetting through 
a syringe. Precipitation of  RNA by LiCI was allowed to proceed for 6-24 h 
at 0~  After centrifugation, the pellet was dissolved in 10 mM Tris HC1 
(pH 7.5)  -  0.5%  SDS-1  mM ethylenedinitrilotetraacetic acid, extracted 
once with phenol and once with phenol-ehloroform-isoamylalcobol  (25:24:1) 
before ethanol precipitation (la). Yields varied between 10to 30 I~g of RNA 
per dish. RNA samples (8-12 [.tg) were subjected to electrophoresis  in 1.2 % 
formaldehyde-agarose gels and transferred onto a  nylon membrane (Hy- 
bond N; Arnersham Corp.) by standard procedures (20). Hybridization and 
final washes of  the blots wore performed according to manuals of  membrane 
suppliers. The AChR a-subunit single-stranded probe (3) was synthesized 
from a DNA fragment of  500 nucleotides containing  120 nucleotides of  exon 
P2 of the chicken AChR a-subunit gene (17) and labeled by a[32P]dATP 
(800 Ci/mmol; Amersham Corp.). The actin probe (giR of Dr. S. Alonso) 
was a  1,150-bp mouse eDNA insert in plasmid pAIA1 derived from cyto- 
skeletal I~-aetin mRNA, as determined from its 3' untranslated sequence (1, 
24).  It was labeled according to the Amersham multiprime procedure by 
a[32P]dCrP (Amersham Corp.; 800 Ci/mmol). Autoradiograms of the hy- 
bridized blots were scanned with a densitometer using appropriate expo- 
sures to obtain calibration curves. 
Results 
Effects of CGRP, CT, and TTX on the Levels Of  AChR 
and AChR a-Subunit mRNA 
As previously described  (14, 25), exposure of primary cul- 
tures of chick myotubes to 10  -7 M CGRP increased the level 
of surface AChR by ,~30%.  Parallel results were obtained 
Table L Parallel Variation of Total and Surface 
[ml]aBGT-binding  Sites in CGRP- or TPA-treated 
Chick Myotubes in Culture 
Total  ['25I]aBGT sites*  Surface  [125I]aBGT sites* 
(fraction of control)  (fraction of control) 
Control  1  1  w 
CGRP  1.25  +  0.02  1.26  +  0.05 
TPA  0.60  •  0.10  0.47  5:0.05 
* Results are averages :t: SD of two separate experiments with three culture 
dishes in each experiment. 
* Results  are averages  5:  SD of two separate  experiments with two culture 
dishes in each experiment. 
w For example, in one experiment surface [l~I]aBGT-binding  sites were ,070 
fmol and total [12sI]aBGT-binding sites ,0135 fmol per control 35-mm dishes. 
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mRNA levels compared with its effect on surface [mI]aBGT-binding 
sites in cultured chicken myotubes.  After 6 d in culture, chick myo- 
tubes were treated with CGRP (10  -7 M), TTX (0.1 ~,/ml), CT (25 
ng/ml), or combinations of these agents. After 30 h of incubation, 
total RNA was extracted and Northern blot analysis was performed 
as described in Materials  and Methods. Size markers were chicken 
rRNAs. Each track contained 10 pg of  total RNA. In the experiment 
shown, relative  scanning of the control track was performed with 
a more exposed autoradiogram and normalized back to the other 
tracks.  Results  are expressed  as fractions of AChR r  or 
a-actin mRNA levels in control cultures.  Measurements of surface 
[~5I]aBGT-binding  sites were conducted in parallel  and averaged 
on two culture dishes (deviations were negligible in the experiments 
shown), and expressed  as fractions of the sites present  in control 
cultures.  Surface  [t251]aBGT-binding sites  were  usually  in  the 
range of 80-I60 fmol per 35-mm dish.  Each experiment was re- 
peated several times (see Fig. 2).  (B) Effect of TPA on the levels 
of AChR (x-subunit and a-actin mRNA compared to its effect on 
surface  ['25I]aBGT-binding  sites  in  cultured  chicken  myotubes. 
After 6 d in culture,  cells were treated for 24 h with CT (25 ng/ml), 
CGRP (10  -7 M), TTX (0.1 lag/ml), or TPA (20 ng/ml), as indicated 
in the figure. Materials  and Methods were as in A. Each experiment 
was repeated several  times (see Fig. 2). 
when total AChR content was measured instead  of surface 
AChR (Table I). The total content of AChR a-subunit mRNA 
in cultured myotubes was assessed by Northern blot analysis 
with a chicken genomic probe as described in Materials and 
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Figure 2. Levels of  AChR 0t-subunit mRNA (A) and u-actin mRNA 
(B) in cultured myotubes.  (,4) AChR u-subunit mRNA. After 6 d 
in culture, cells were treated with different compounds as indicated, 
total RNA was extracted after various times of incubation except for 
TTX-treated cells (30 h of  treatment in all cases), and Northern blot 
analysis  was performed as described in Materials  and Methods. 
The amount of ct-actin mRNA was obtained by scanning autoradio- 
grams of blot hybridizations  such as those in Fig.  1 in n different 
experiments.  Results are expressed  as fractions of AChR a-subunit 
mRNA in control cultures with their standard deviation.  (B) r 
tin mRNA under some of the experimental  conditions shown in A. 
Note that the same blots were used successively with the a-subunit 
and the actin probes. Results are expressed  as fractions of ct-actin 
mRNA measured in control cultures. 
Methods.  As shown in Figs.  1 and 2, CGRP increased the 
level of AChR a-subunit mRNA by about threefold without 
changing a-, 13-, and 7-actins mRNA levels.  Similar results 
were obtained with 25 ng/ml CT.  When CT was added to- 
gether with CGRP,  no further increase of AChR ct-subunit 
mRNA took place (Figs.  1 and 2 A). When added to CGRP- 
or CT-treated  cultures,  0.1  lag/ml TTX  increased the total 
content of AChR a-subunit  mRNA on top of the increase 
caused by CGRP or CT alone (Figs.  1 and 2 A). Under the 
same experimental  conditions,  levels of surface [~25I]r 
were measured: their variations were qualitatively similar to 
those of  AChR ct-subunit mRNA levels. However, the magni- 
tude of the latter  were at least  twofold higher than the in- 
creases in surface AChR (Fig.  1). 
Effects of TPA on AChR Biosynthesis 
Addition  of TPA  to  cultured  embryonic  chick  myotubes 
caused  a  significant  decrease  of  the  number  of  surface 
[~2~I]aBGT-binding sites.  No significant effect was noticed 
at TPA concentrations below 1 ng/ml, and the response was 
maximal at 10 ng/ml TPA after a 40-h incubation period (Fig. 
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Figure 3. Effect of TPA on surface AChR. (A) Dose-response curve 
of the effect of TPA on [~2~I]ctBGT-binding  sites in cultured myo- 
tubes after a 40-h incubation period. Number of surface AChR sites 
are expressed as the percentage of [~2~I]ttBGT sites in parallel un- 
treated cultures.  (B) Time course of the evolution of [125I]ctBGT- 
binding sites in TPA (20 ng/ml)-treated and control cultures. Each 
of these experiments was repeated at least twice.  Each point is a 
mean of two different culture  dishes,  with the bar indicating the 
variation between the two. 
3 A). 3 h after the addition of TPA (20 ng/ml), this effect was 
already noticeable, and it reached its maximum after 24 h of 
treatment (Fig. 3 B). No further decrease was found between 
30 and 40 h  (not shown).  The reduction in the number of 
[12~I]ctBGT-binding  sites  caused  by  TPA  averaged  45% 
(25-60% of control values in nine separate experiments). A 
similar but smaller effect was obtained on total AChR (Table 
I).  The 4-ct-phorbol  12-13 didecanoate  (20 ng/ml),  which 
does not activate protein kinase C  (27),  had no significant 
effect on AChR number in these cultured muscle cells. 
The rate of insertion of AChR into the sarcolemmal mem- 
brane was measured by following the time course of the in- 
crease of [L~ctBGT-binding sites after blocking preexisting 
surface AChR by unlabeled ~tBGT. Insertion of new surface 
AChR proceeded linearly for several hours in control and in 
TPA- or CGRP-treated cultures (Fig. 4 A). However, TPA de- 
creased the rate of insertion of surface AChR to about one- 
third of control. In contrast, this rate was increased by one- 
third relative to control in cultures pretreated with  10  -7 M 
CGRP (Fig. 4 A). These results correlate well with the ob- 
served variations in surface [~25I]ctBGT-binding  sites (Fig.  1). 
In  the  absence  of cytosine  arabinoside,  the  density  of 
mononucleated cells (partly fibroblasts) increased by over 
10-fold  (as judged by phase-contrast microscopy). Yet,  no 
modification  of the  effect of TPA  on the  level of surface 
AChR was observed (data not shown). The presence of con- 
taminating fibroblasts thus does not modify the effect of TPA 
on surface AChR content. 
In TPA-treated cells and in the presence of cytosine ara- 
binoside, the total protein content decreased by 15  +  10% 
(SD; n  =  3) compared to untreated cultures and [35S]methi- 
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Figure 4. (A) Insertion of [12~I]otBGT-binding  sites into the surface 
of  TPA-treated,  CGRP-treated,  and  control  myotubes.  Measure- 
merits were done after a 24-h pretreatment with TPA (20 ng/ml) or 
CGRP (10  -7 M). Preexisting surface [~25I]~-binding sites were 
then blocked by ctBGT. Each of these experiments was repeated 
twice. Each point is a mean of  two culture dishes, with the bar indi- 
cating the variation between the two. (B) Time course of the loss 
of bound [t25I]ctBGT in TPA-treated and control cultures.  After a 
24-h preincubation  with TPA (20 ng/ml),  TPA-treated cells and 
control cultures were labeled with [~25I]~tBGT  as described in Ma- 
terials and Methods. Their preincubation medium was then added 
back to the cultures, with an extra dose of TPA (another 20 ng/ml) 
for the TPA-treated cells. Remaining bound radioactivity was deter- 
mined after various times of incubation. 
onine incorporation was reduced by 20 +  5 % (n =  2). Since, 
under these culture conditions, mononucleated cells did not 
account for more than ,x,5 % of the total population of cells 
(as judged by phase-contrast microscopy), the myotubes ap- 
pear to be the main target of this •20%  inhibition of protein 
synthesis. Yet, this effect does not suffice to account for the 
average 45 % decrease of surface AChR caused by TPA. 
To test for a possible effect of TPA on AChR degradation 
rate,  the  kinetics  of degradation  of the  [~25I]aBGT-AChR 
complex were measured in control cultures and in cultures 
preincubated for 24 h with TPA (20 ng/ml). No significant 
difference  was  observed (Fig.  4  B).  TPA  thus  primarily 
affects the biosynthesis of the AChR rather than its degra- 
dation. 
Effects of  CGRP, CT, and TTX on AChR Metabolism 
in TPA-treated Cells 
As mentioned above, CGRP and CT caused increases of sur- 
face AChR  which  are additive to the  increase caused by 
TXX.  Interestingly,  CT  still  increased  the  surface AChR 
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effect for CGRP was only noticed in two out of the five ex- 
periments (Fig.  1 B). In contrast, in the presence of TPA, 
the effect of TTX on surface AChR was systematically abol- 
ished (Fig.  1 B). 
Parallel analysis of mRNA content by Northern blots re- 
vealed that the level of AChR ~t-subunit  mRNA was  not 
affected by TPA  (or  slightly increased) relative to AChR 
a-subunit mRNA level in control cultures (Figs. 1 B and 2 
A).  In contrast, the level  of ~t-actin mRNA decreased by 
"-,50% (Figs. 1 B and 2 B) while that of 13- and 3,-actins in- 
creased ,~fivefold (Fig. 2 B). CGRP and CT still increased 
the content in AChR ct-subunit  mRNA in the presence of 
TPA (Figs.  1 B and 2 A). Consistent with a previous study 
(17),  TTX  augmented up to  10-fold the content of AChR 
~t-subunit mRNA (after 30 h of  treatment). However, in TPA- 
treated cells, this effect of TTX on AChR ~t-subunit mRNA 
content was totally abolished (Figs.  1 B and 2 A). 
Discussion 
CGRP, a neuropeptide which coexists with acetylcholine in 
spinal cord motor neurons, has been previously shown to in- 
crease the number of AChR sites in primary cultures of chick 
skeletal muscle (14, 25). The present results further demon- 
strate that, correlatively, CGRP increases (by about three- 
fold) the level of AChR r  mRNA without signifi- 
cantly affecting  the level of r  mRNA, a major muscular 
component.  Such an increase may result from a  specific 
stimulation of ~t-subunit gene transcription or from a stabili- 
zation of the r  mRNA (11). Nuclear run-on experi- 
ments should decide in favor of  one of  these two possibilities. 
The amplitude of this increase in mRNA levels appears 
significantly larger (about twofold) than the increase of total 
and surface aBGT-binding sites as well as of the rate of 
AChR appearance at the surface of the myotubes. A similar 
difference between AChR r  mRNA and AChR pro- 
tein content has already been noticed in the case of TTX 
blockade of the spontaneous electrical activity of cultured 
myotubes (17). Posttranscriptional events which include the 
covalent  modification  and  conformational  maturation  of 
AChR subunits, their assembly into the a2137~ pentamer, 
and their transport to the cell surface via the Golgi apparatus 
may account for this difference (23). 
Electrical activity of muscle fibers in culture and in vivo 
is known to repress AChR biosynthesis (9,  15, 29).  In cell 
cultures, CGRP causes an increase in AChR number which 
appears independent of the electrical activity of the muscle 
fibers, suggesting that CGRP and electrical activity regulate 
AChR biosynthesis via different intraceUular pathways (14). 
These results have now been extended to the AChR r 
mRNA level. Moreover, in our initial observations (14), it 
was noticed that CI', an activator of adenytate cyclase, also 
increased AChR number (as already described with dibuty- 
ryl cyclic AMP [2] and with CT [4,  19]), but this effect was 
not found additive with that of CGRP. Interestingly, the same 
observations hold at the mRNA level, further supporting a 
contribution of cyclic AMP to the regulation of AChR bio- 
synthesis by CGRP.  Consistent with such  a  mechanism, 
CGRP has recently been shown to increase cyclic AMP level 
in cultured myotubes (18) and in mouse diaphragm (30), and 
to activate adenylate cyclase in chick muscle membranes 
(18). 
To investigate the possible involvement of protein kinase 
C in AChR biosynthesis, the phorbol ester TPA, an activator 
of  protein kinase C (6, 27), was applied to chick myotube cul- 
tures. TPA has already been shown to exert a pleiotropic ac- 
tion on cultured myotubes (10) and to modulate their terminal 
differentiation. This effect could account for the observed in- 
crease of nonmuscular I~- and T-actin mRNA levels and for 
the decrease of muscular ct-actin mRNA level. An increase 
of l~ and ~t-actin mRNA levels has also been recently re- 
ported in BC3H1 ceils exposed to other mitogenic factors: 
20% FCS and fibroblast growth factor (35). Of particular in- 
terest for the present study, TPA caused a specific decrease 
of surface and total AChR content in cultured myotubes as 
well as a correlative decrease of the rate of AChR insertion 
into the sarcolemmal membrane. Yet, general protein syn- 
thesis was hardly diminished; AChR lifetime did not change 
and AChR a-subunit mRNA level  remained constant (or 
slightly increased).  Under these culture conditions,  TPA 
thus primarily affects posttranscriptional events in the matu- 
ration of AChR. Posttranscriptional regulation of AChR bio- 
synthesis has also been observed with differentiated BC3H-1 
cells in culture.  When forced back into the cell cycle by 
refeeding with 20% FCS, AChR a-subunit mRNA level in- 
creased although AChR expression at the cell surface was 
completely blocked (23).  Also, an inhibition of AChR as- 
sembly by electrical activity has been suggested in primary 
cultures of embryonic rat muscle cells (5). 
It is noteworthy that muscle electrical activity has been 
proposed to stimulate phosphatidylinositide metabolism (34), 
and, thus,  may enhance protein kinase C  activity via the 
resulting production of diacylglycerol (27). Exposure of the 
cells to TPA might then reproduce the effect of electrical 
stimulation on AChR biosynthesis. Although TPA did not 
significantly  modify the level of  AChR mRNA in cells where 
AChR expression is already repressed by spontaneous elec- 
trical activity (9,  15, 29), TPA did completely block the in- 
crease of AChR biosynthesis caused by TTX. In contrast, the 
accumulation of AChR a-subunit mRNA elicited by CGRP 
and CT persisted in TPA-treated  myotubes. Therefore, the 
present data do not rule out the possible involvement of pro- 
tein kinase C in linking muscle electrical activity to AChR 
r  mRNA content. Moreover, calcium has also been 
shown to play a  significant role in the regulation of AChR 
biosythesis by muscle activity (15, 29), and the interactions 
between calcium and protein kinase C are now well docu- 
mented (27). In any case, these data further strengthen the 
conclusion that CGRP and electrical activity regulate AChR 
gene expression via different second messenger systems (14). 
Our results are consistent with a model (9) according to 
which, (a) in the adult muscle, the sarcolemmal nuclei that 
underlie the endplate are in a state of differentiation different 
from those located in extrajunctional cytoplasm (22), and (b) 
the development and maintenance of this pattern involves 
distinct intracellular signaling pathways in extrajunctional 
and junctional areas. Tentatively, one may thus suggest that, 
during development, CGRP, co-released with acetylcholine 
by the motor nerve ending, would increase the expression of 
the genes coding for the AChR via the cyclic AMP cascade 
in subneural areas while, in extrajunctional nuclei, muscle 
membrane electrical activity would repress their transcrip- 
Fontaine et aL CGRP, Muscle Activity, and AChR Biosynthesis  1341 tion by an intracellular pathway involving calcium (19) and, 
more  speculatively,  the  activation  of protein  kinase  C. 
Whereas the in vivo role of muscle electrical activity in 
AChR gene regulation is now well established, the actual rel- 
evance of CGRP to the development of the neuromuscular 
junction remains to be derhonstrated. Interestingly, a possi- 
ble contribution of cyclic AMP to synapse stabilization has 
been proposed on the basis of in vitro results (26) and CGRP 
appears  to  be  one  candidate  "anterograde  factor"  (7,  9) 
which, among others, could mediate this regulation. 
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